Unlike type II IFNγ, IFNα, IFNλ, TNFα, or TRAIL alone or in combination with Smac mimetic AZD5582 had very minor effects on cell viability in the examined NSCLC cell lines. Here, IFNG is linked to non-small cell lung carcinoma.